Mutations on the α2-Globin Gene That May Trigger α⁺-Thalassemia

References

• Lauer J, Shen CK, Maniatis T. The chromosomal arrangement of human α-like globin genes: Sequence homology and α-globin gene deletions. Cell. 1980;20(1):119–130
   PubMed Web of Science ®Google Scholar
• Higgs DR, Vickers MA, Wilkie AOM, et al. A review of the molecular genetics of the human α-globin gene cluster. Blood. 1989;73(5):1081–1104
   PubMed Web of Science ®Google Scholar
• Rugless MJ, Fisher CA, Old JM, et al. A large deletion in the human α-globin cluster caused by a replication error is associated with an unexpectedly mild phenotype. Hum Mol Genet. 2008;17(19):3084–3093
   PubMed Web of Science ®Google Scholar
• Higgs DR. The molecular basis of α-thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, Eds. Disorders of Hemoglobin Genetics, Pathophysiology, and Clinical Management, 2nd ed. New York, NY: Cambridge University Press. 2001:405–430
   Google Scholar
• Fucharoen S, Winichagoon P, Pootrakul P, et al. Differences between two types of Hb H disease, α-thalassemia 1/α-thalassemia 2 and α-thalassemia 1/Hb Constant Spring. Birth Defects Orig Arctic Ser. 1987;23(5A):309–315
   PubMedGoogle Scholar
• Hadavi V, Taromchi AH, Malekpour M, et al. Elucidating the spectrum of α-thalassemia mutations in Iran. Haematologica. 2007;92(7):992–993
   PubMed Web of Science ®Google Scholar
• Neishabury M, Oberkanins C, Moheb LA, et al. High prevalence of the –α3.7 deletion among thalassemia patients in Iran. Hemoglobin. 2003;27(1):53–55
   PubMed Web of Science ®Google Scholar
• Garshasbi M, Oberkanins C, Law HY, et al. α-globin gene deletion and point mutation analysis among in Iranian patients with microcytic hypochromic anemia. Haematologica. 2003; 88(10):1196–1197
   PubMed Web of Science ®Google Scholar
• Najmabadi H, Ghamari A, Sahebjam F, et al. Fourteen-year experience of prenatal diagnosis of thalassemia in Iran. Community Genet. 2006;9(2):93–97
   PubMedGoogle Scholar
• Higgs DR. α Thalassaemia. Bailliére’s Clin Haematol. 1993;6:117–150
   PubMed Web of Science ®Google Scholar
• Wajcman H, Traeger-Synodinos J, Papassotiriou I, et al. Unstable and thalassemic α chain hemoglobin variants: A cause of Hb H disease and thalassemia intermedia. Hemoglobin. 2008;32(4):327–349
   PubMed Web of Science ®Google Scholar
• Liebhaber SA, Cash FE, Ballas SK. Human α-globin gene expression. The dominant role of the α 2-locus in mRNA and protein synthesis. J Biol Chem. 1986;261(32):15327–15333
   PubMed Web of Science ®Google Scholar
• Steinberg MH, Forget BG, Higgs DR, et al. Clinical and laboratory features of the α-thalassemia syndromes. Disorders of Hemoglobin Genetics, Pathophysiology, and Clinical Management. New York, NY: Cambridge University Press. 2001:431–469
   Google Scholar
• Liang ST, Wong VC, So WW, et al. Homozygous α-thalassaemia: Clinical presentation, diagnosis and management. A review of 46 cases. Br J Obstet Gynaecol. 1985;92(7):680–684
   PubMedGoogle Scholar
• Farashi S, Garous NF, Ashki M, et al. Homozygosity for the AATAAA > AATA– – polyadenylation site mutation on the α2-globin gene causing transfusion-dependent Hb H disease in an Iranian patient: A case report. Hemoglobin. (in press)
   Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215
   PubMed Web of Science ®Google Scholar
• Baysal E, Huisman THJ. Detection of common deletional α-thalassemia-2 determinants by PCR. Am J Hematol. 1994;46(3):208–213
   PubMed Web of Science ®Google Scholar
• ViennaLab Product brochure (http://www.viennalab.com/filemana ger/documents/)
   Google Scholar
• Gatta V, Scarciolla O, Gaspari AR, et al. Identification of deletions and duplications of the DMD gene in affected males and carrier females by multiple ligation probe amplification (MLPA). Hum Genet. 2005;117(1):92–98
   PubMed Web of Science ®Google Scholar
• Harteveld CL, Refaldi C, Cassinerio E, et al. Segmental duplications involving the α-globin gene cluster are causing β-thalassemia intermedia phenotypes in β-thalassemia heterozygous patients. Blood Cells Mol Dis. 2008;40(3):312–316
   PubMed Web of Science ®Google Scholar
• Harteveld CL, Voskamp A, Phylipsen M, et al. Nine unknown rearrangements in 16p13.3 and 11p15.4 causing α- and β-thalassemia characterized by high resolution multiplex ligation-dependent probe amplification. J Med Genet. 2005;42(12):922–931
   PubMed Web of Science ®Google Scholar
• Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248–249
   PubMed Web of Science ®Google Scholar
• Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073–1081
   PubMed Web of Science ®Google Scholar
• Tavtigian SV, Deffenbaugh AM, Yin L, et al. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet. 2006;43(4):295–305
   PubMed Web of Science ®Google Scholar
• Mathe E, Olivier M, Kato S, et al. Computational approaches for predicting the biological effect of p53 missense mutations: A comparison of three sequence analysis based methods. Nucleic Acids Res. 2006; 34(5):1317–1325
   PubMed Web of Science ®Google Scholar
• Tchernitchko D, Goossens M, Wajcman H. In-silico prediction of the deleterious effect of a mutation: Proceed with caution in clinical genetics. Clin Chem. 2004;50(11):1974–1978
   PubMed Web of Science ®Google Scholar
• Bayat N, Farashi S, Hafezi-Nejad N, et al. Novel mutations responsible for α-thalassemia in Iranian families. Hemoglobin. 2013;37(2):148–159
   PubMed Web of Science ®Google Scholar
• Kan YW. Molecular pathology of α-thalassemia. Ann N Y Acad Sci. 1985;445:28–36
   PubMed Web of Science ®Google Scholar
• Russell JE, Morales J, Liebhaber SA. The role of mRNA stability in human globin gene expression. Prog Nucleic Acid Res Mol Biol. 1997;57:259–287
   Google Scholar
• Liebhaber SA, Coleman MB, Adams JG 3rd, et al. Molecular basis for nondeletion α-thalassemia in American blacks. α2(116GAG—UAG). J Clin Invest. 1987;80(1):154–159
   PubMed Web of Science ®Google Scholar
• Twomey AP, Brasch JM, Betheras FR, Bowden DK. A new α2-globin gene [codon 90 (AAG→TAG)] nonsense mutation. Hemoglobin. 2003;27(4):261–265
   PubMed Web of Science ®Google Scholar
• Siala H, Fattoum S, Messaoud T, et al. A novel α-thalassemia nonsense mutation in codon 23 of the α2-globin gene (GAG→TAG) in a Tunisian family. Hemoglobin. 2004;28(3):249–254
   PubMed Web of Science ®Google Scholar
• Harteveld CL, Wijermans PW, van Delft P, et al. An α-thalassemia phenotype in a Dutch Hindustani, caused by a new point mutation that creates an alternative splice donor site in the first exon of the α2-globin gene. Hemoglobin. 2004;28(30):255–259
   PubMed Web of Science ®Google Scholar
• Harteveld CL, Yavarian M, Zorai A, et al. Molecular spectrum of α-thalassemia in the Iranian population of Hormozgan: Three novel point mutation defects. Am J Hematol. 2003;74(2):99–103
   PubMed Web of Science ®Google Scholar
• Harteveld CL, Heister JG, Giordano PC, et al. An IVS1-116 (A→G) acceptor splice site mutation in the α2 globin gene causing α+ thalassaemia in two Dutch families. Br J Haematol. 1996; 95(3):461–466
   PubMed Web of Science ®Google Scholar
• Cürük MA, Baysal E, Gupta RB, et al. An IVS-I-117 (G→A) acceptor splice site mutation in the α1-globin gene is a nondeletional α-thalassaemia-2 determinant in an Indian population. Br J Haematol. 1993;85(1):148–152
   PubMed Web of Science ®Google Scholar
• Orkin SH, Goff SC, Hechtman RL. Mutation in an intervening sequence splice junction in man. Proc Natl Acad Sci USA. 1981;78(8):5041–5045
   PubMed Web of Science ®Google Scholar
• Harteveld CL, Beijer C, van Delft P, et al. α-Thalassaemia as a result of a novel splice donor site mutation of the α1-globin gene. Br J Haematol. 2000;110(3):694–698
   PubMed Web of Science ®Google Scholar
• Chui DHK, Fucharoen S, Chan V. Hemoglobin H disease: Not necessarily a benign disorder. Blood. 2003;101(3):791–800
   PubMed Web of Science ®Google Scholar
• Noguera NI, González FA, Dávoli RA, et al. A novel splice acceptor site mutation of the α2-globin gene causing α-thalassemia. Hemoglobin. 2001;25(3):311–315
   PubMed Web of Science ®Google Scholar